Summary
In a balanced, fully crossed-over, double-blind investigation on healthy young adults, 5 mg and 10 mg of nitrazepam reduced parieto-occipital EEG activity more slowly but more markedly than 100 mg and 200 mg of sodium amylobarbitone. Differences between the drugs, but not between doses, were statistically significant. All four treatments differed significantly from placebo in respect of the level attained after sixty minutes. Differences in speed of onset were detected within six minutes of giving the drug by mouth.
Similar content being viewed by others
References
Baum, G., C. E. S. Bill, P. Freeling, R. V. H. Goulder, S. Lazarus, J. R. Sale, P. T. Smith, and H. W. K. Thompson: Sedation with a new non-barbiturate compound. Practitioner 195, 366–368 (1965).
Cochrane, W. G., and G. M. Cox: Experimental Designs. London: Chapman and Hall 1957.
Davies, C., and S. Levine: A controlled comparison of nitrazepam (Mogadon) with sodium amylobarbitone as a sleep-inducing agent. Brit. J. Psychiat. 113, 1005–1008 (1967).
Friedman, M.: A comparison of alternative tests of significance for the problem of m rankings. Ann. math. statist. 11, 86–92 (1940).
Haider, I.: A double-blind controlled trial of a non-barbiturate hypnotic-nitrazepam. Brit. J. Psychiat. 114, 337–343 (1968).
Johnson, L. H.: Nomography and empirical equations. London: Chapman and Hall 1952.
Loomis, A., E. N. Harvey, and G. A. Hobart: Cerebral states during sleep, as studied by human brain potentials. J. exp. Psychol. 21, 127–144 (1937).
Malpas, A., and C. R. B. Joyce: Effecets of nitrazepam, amylobarbitone and placebo on some perceptual, motor and cognitive tasks in normal subjects. Psychopharmacologia (Berl.) 14, 167–177 (1969).
Simon, C. W., and W. H. Emmons: EEG consciousness and sleep. Science 124, 1066–1069 (1956).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volavka, J.V., Joyce, C.R.B., Maloney, M.J. et al. Effect of nitrazepam, amylobarbitone sodium and placebo on the electroencephalogram of normal subjects. Psychopharmacologia 14, 178–183 (1969). https://doi.org/10.1007/BF00404215
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00404215